BDX insider transactions

EVP, Chief Revenue Officer Feld Michael sold $11,244 worth of shares (74 units at $151.94) as part of a pre-agreed trading plan, decreasing direct ownership by 0.35% to 21,159 units (SEC Form 4)

SEC Form 4 filed by Neal Shana Carol

SEC Form 4 filed by Feld Michael

EVP and General Counsel Minnix Lanesha was granted 7,492 shares (SEC Form 4)

New insider Minnix Lanesha claimed no ownership of stock in the company (SEC Form 3)

Interim CFO Roque Vitor was granted 931 shares, increasing direct ownership by 17% to 6,510 units (SEC Form 4)

SVP Controller & CAO Spikner Pamela L. was granted 931 shares, increasing direct ownership by 39% to 3,323 units (SEC Form 4)

EVP, Chief Revenue Officer Feld Michael sold $13,638 worth of shares (75 units at $181.84), decreasing direct ownership by 0.35% to 21,308 units (SEC Form 4)

Director Scott Bertram L sold $174,027 worth of shares (953 units at $182.61), decreasing direct ownership by 3% to 36,763 units (SEC Form 4)

Large owner Becton Dickinson & Co disposed of 284,771,350 shares, closing all direct ownership in the company (SEC Form 4)

New insider Urbini Massimiliano claimed ownership of 4,133 shares (SEC Form 3)

SEC Form 4 filed by Director Huffines Robert Luther

SEC Form 4 filed by Director Byington Carrie L

SEC Form 4 filed by Director Jones Christopher Ian Montague

Director Henderson Jeffrey William was granted 1,098 shares, increasing direct ownership by 14% to 9,143 units (SEC Form 4)

Director Eckert R Andrew was granted 1,098 shares, increasing direct ownership by 12% to 10,423 units (SEC Form 4)

Director Byington Carrie L was granted 1,098 shares, increasing direct ownership by 28% to 5,018 units (SEC Form 4)

Director Hayes Gregory was granted 1,098 shares, increasing direct ownership by 18% to 7,159 units (SEC Form 4)

Director Brown William M was granted 1,098 shares, increasing direct ownership by 31% to 4,663 units (SEC Form 4)

Director Huffines Robert Luther was granted 1,098 shares, increasing direct ownership by 607% to 1,279 units (SEC Form 4)

Director Jones Christopher Ian Montague was granted 1,098 shares, increasing direct ownership by 5% to 24,304 units (SEC Form 4)

Director Ring Timothy M was granted 1,098 shares, increasing direct ownership by 2% to 59,160 units (SEC Form 4)

Director Scott Bertram L was granted 1,098 shares, increasing direct ownership by 3% to 37,716 units (SEC Form 4)

Director Waldstreicher Joanne was granted 1,098 shares, increasing direct ownership by 48% to 3,391 units (SEC Form 4)

Director Wright Jacqueline was granted 1,098 shares, increasing direct ownership by 607% to 1,279 units (SEC Form 4)

EVP, CRO & Pres. Life Sciences Feld Michael sold $15,205 worth of shares (75 units at $202.73), decreasing direct ownership by 0.45% to 16,431 units (SEC Form 4)

SVP Controller & CAO Spikner Pamela L. covered exercise/tax liability with 84 shares, decreasing direct ownership by 4% to 1,832 units (SEC Form 4)

EVP & Pres Med.Essntl&BioPharm Garrison Michael David exercised 3,054 shares at a strike of $167.91, returned $512,886 worth of shares to the company (2,454 units at $209.00) and sold $334,005 worth of shares (1,610 units at $207.46), decreasing direct ownership by 8% to 12,095 units (SEC Form 4)

EVP and Chief ISC Officer Shan David covered exercise/tax liability with 44 shares, decreasing direct ownership by 0.49% to 8,926 units (SEC Form 4)

New insider Becton Dickinson & Co claimed ownership of 1,000 shares (SEC Form 3)

EVP, CRO & Pres. Life Sciences Feld Michael sold $14,510 worth of shares (74 units at $196.08), decreasing direct ownership by 0.45% to 16,506 units (SEC Form 4)

EVP & Pres Med.Essntl&BioPharm Garrison Michael David sold $123,303 worth of shares (629 units at $196.03), decreasing direct ownership by 5% to 13,105 units (SEC Form 4)

New insider Roque Vitor claimed ownership of 4,477 shares (SEC Form 3)

EVP, CRO & Pres. Life Sciences Feld Michael sold $14,502 worth of shares (75 units at $193.36), decreasing direct ownership by 0.45% to 16,580 units (SEC Form 4)

Director Wright Jacqueline was granted 180 shares (SEC Form 4)

Director Huffines Robert Luther was granted 180 shares (SEC Form 4)

New insider Huffines Robert Luther claimed no ownership of stock in the company (SEC Form 3)

New insider Wright Jacqueline claimed no ownership of stock in the company (SEC Form 3)

EVP & President, Greater Asia Mocherla Pavan Kumar was granted 2,916 shares, increasing direct ownership by 102% to 5,763 units (SEC Form 4)

EVP and Chief ISC Officer Shan David was granted 4,529 shares and covered exercise/tax liability with 134 shares, increasing direct ownership by 96% to 8,970 units (SEC Form 4)

EVP and Chief People Officer Neal Shana Carol was granted 10,252 shares and covered exercise/tax liability with 2,454 shares, increasing direct ownership by 58% to 21,326 units (SEC Form 4)

EVP and President, EMEA Goette Roland was granted 3,143 shares and covered exercise/tax liability with 138 shares, increasing direct ownership by 21% to 17,222 units (SEC Form 4)

EVP & Pres Med.Essntl&BioPharm Garrison Michael David was granted 10,616 shares and covered exercise/tax liability with 1,769 shares, increasing direct ownership by 181% to 13,734 units (SEC Form 4)

EVP, CRO & Pres. Life Sciences Feld Michael was granted 8,829 shares and covered exercise/tax liability with 419 shares, increasing direct ownership by 102% to 16,655 units (SEC Form 4)

SEC Form 4 filed by Becton Dickinson and Company

EVP & President Interventional Byrd Richard was granted 8,832 shares and covered exercise/tax liability with 1,719 shares, increasing direct ownership by 106% to 13,849 units (SEC Form 4)

EVP & President Connected Care Muhsin Bilal was granted 9,530 shares, increasing direct ownership by 78% to 21,751 units (SEC Form 4)

Chairman, CEO and President Polen Thomas E Jr was granted 22,521 shares and covered exercise/tax liability with 17,421 shares, increasing direct ownership by 5% to 105,471 units (SEC Form 4)

SEC Form 4 filed by Becton Dickinson and Company

Director Scott Bertram L sold $38,318 worth of shares (217 units at $176.58), decreasing direct ownership by 0.60% to 35,816 units (SEC Form 4)

SEC Form 4 filed by Director Byington Carrie L

SEC Form 4 filed by Director Jones Christopher Ian Montague

EVP & President, Life Sciences Feld Michael sold $10,603 worth of shares (57 units at $186.01), decreasing direct ownership by 0.69% to 8,245 units (SEC Form 4)

EVP & President, Life Sciences Feld Michael sold $10,500 worth of shares (58 units at $181.03), decreasing direct ownership by 0.69% to 8,302 units (SEC Form 4)

Director Fraser Claire sold $171,938 worth of shares (917 units at $187.50), decreasing direct ownership by 4% to 22,226 units (SEC Form 4)

EVP & Chief Financial Officer Delorefice Christopher covered exercise/tax liability with 278 shares, decreasing direct ownership by 1% to 21,221 units (SEC Form 4)

EVP & President Interventional Byrd Richard covered exercise/tax liability with 216 shares, decreasing direct ownership by 3% to 6,736 units (SEC Form 4)

EVP & President, Life Sciences Feld Michael sold $11,285 worth of shares (57 units at $197.99), decreasing direct ownership by 0.68% to 8,360 units (SEC Form 4)

EVP & President, Life Sciences Feld Michael covered exercise/tax liability with 773 shares, decreasing direct ownership by 8% to 8,417 units (SEC Form 4)

Director Hayes Gregory bought $1,005,742 worth of shares (5,250 units at $191.57), increasing direct ownership by 660% to 6,046 units (SEC Form 4)